Teva Pharmaceuticals USA Inc. has voluntarily recalled 4,941 bottles of Tretinoin Capsules (10 mg), a prescription medication used to treat certain types of leukemia. The recall was initiated because the capsules failed dissolution testing, meaning the drug may not dissolve properly in the body as intended. No incidents or injuries have been reported to date in connection with this recall.
If the medication does not dissolve correctly, it may result in lower-than-intended levels of the drug in the patient's bloodstream. This could potentially reduce the effectiveness of the treatment for patients with serious medical conditions.
You have 2 options:
Rx Only; Manufactured in North Wales, PA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.